Related Experiment Video
Updated: Jun 12, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Reduced Mortality With Treatment of Anxiety and Depression Among Head and Neck Cancer Survivors
Tyler J Gallagher1, Matthew E Lin2, Ian Kim3
1Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
Objective:
This study seeks to evaluate the relationship between anxiety and/or depressive disorders and survival among head and neck cancer (HNC) survivors as well as the impact of treatment of mental health disorders on survival.
Methods:
This is a retrospective cohort study utilizing deidentified electronic medical record data from TriNetX. Cohorts of adults were generated, including HNC survivors with and without a diagnosis of selected anxiety and/or depressive disorders. Among those with a selected anxiety and/or depressive disorder, cohorts were created for those with and without treatment of those disorders. Finally, Kaplan-Meier curves were utilized to compare the risk of mortality between groups after propensity score matching groups for relevant demographic and medical characteristics.
Results:
Among 258,259 adult HNC survivors, 65,486 (25.4%) were diagnosed with an anxiety and/or depressive disorder. After propensity score matching between groups, adults with an anxiety and/or depressive disorder (HR: 1.07 [95% CI: 1.05-1.09]), an anxiety disorder (HR: 1.08 [95% CI: 1.05-1.10]), but not a depressive disorder (HR: 1.01 [95% CI: 0.99-1.04]) had a significantly higher risk of mortality than those without. Among those diagnosed with HNC and anxiety and/or depressive disorders, 39,923 (61.0%) received pharmacotherapy and/or psychotherapy. Those treated with pharmacotherapy and/or psychotherapy (HR: 0.94 [95% CI: 0.91-0.97]), pharmacotherapy (HR: 0.94 [95% CI: 0.91-0.97]), or psychotherapy (HR: 0.75 [95% CI: 0.68-0.82]) had a lower risk of mortality compared to those without.
Conclusions:
This retrospective cohort study suggests that a history of anxiety and/or depressive disorder is associated with worse survival among HNC survivors and that treatment of that anxiety and/or depressive disorder may ameliorate that increased risk of mortality.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Acute Coronary Syndrome IV: Interprofessional Care
Cancer Survival Analysis
Stress Prevention and Stress Management Techniques III
The Role of Exercise in Stress Management
Regular physical activity is essential for reducing stress and promoting cardiovascular health. Exercise strengthens the heart, enhances blood flow, keeps blood vessels flexible, and helps lower blood pressure, all of which reduce the body's stress response. Research shows that adults who exercise regularly have nearly half the...
Psychoneuroimmunology: Diabetes and Cancer
Electroconvulsive Therapy

